Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Scilex Holding Company
AddedFeb 19, 2024
UpdatedJul 4, 2026
Scilex Holding Company

Scilex Holding Company

Public

Scilex, a Sorrento subsidiary, responsibly develops and commercializes branded pharmaceutical products globally.

HQ
Palo Alto, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Scilex Holding Company, a subsidiary of Sorrento, is dedicated to developing and commercializing branded pharmaceutical products with a focus on non-opioid pain management. Located in Palo Alto and San Diego, California, Scilex leverages advanced adhesion and delivery systems, including proprietary patch technology and anti-inflammatory oral solutions, to optimize drug delivery and improve quality of life. Their market focus includes precision dosing for high-risk patients and fast-acting migraine relief.

Scilex has achieved recognition for its innovative approach to pain management, particularly through its proprietary technologies that enhance drug delivery efficacy. As a public company listed on Nasdaq (SCLX), Scilex continues to make significant strides in the pharmaceutical industry, contributing to the global effort to provide safer, non-opioid pain relief options. Their impact is underscored by their commitment to responsible development and commercialization of high-quality pharmaceutical products.

Scilex Holding Company - Similar Companies

Escient Pharmaceuticals logo

Escient Pharmaceuticals

Scienture logo

Scienture

scienture.com

Solace Pharmaceuticals logo

Solace Pharmaceuticals

Assertio Holdings logo

Assertio Holdings

Sollis Therapeutics logo

Sollis Therapeutics

Epalex logo

Epalex

epalex.com

Lydex logo

Lydex

Scynexis logo

Scynexis

scynexis.com

Exalys Therapeutics logo

Exalys Therapeutics

Strategic Science & Technologies logo

Strategic Science & Technologies

Salix Pharmaceuticals logo

Salix Pharmaceuticals

salix.com

Phoenix PharmaLabs logo

Phoenix PharmaLabs

Talphera logo

Talphera

talphera.com

Elite Pharmaceuticals logo

Elite Pharmaceuticals

elitepharma.com

Silo Pharma logo

Silo Pharma

silopharma.com

Scilex Holding Company - Quick Facts

Who are Scilex Holding Company's competitors?

Companies similar to Scilex Holding Company include Escient Pharmaceuticals, Scienture, Solace Pharmaceuticals and Assertio Holdings.

When was Scilex Holding Company founded?

Scilex Holding Company was founded in 2012.

Where is Scilex Holding Company's headquarters located?

Scilex Holding Company's headquarters is located in Palo Alto, CA, US.

When was Scilex Holding Company's last funding round?

Scilex Holding Company's most recent funding round was for $25M (USD) in March 2023.

How much has Scilex Holding Company raised to-date?

As of Mar 21, 2023, Scilex Holding Company has raised a total of $32.5M (USD).

How many employees does Scilex Holding Company have?

Scilex Holding Company has 95 employees as of Feb 10, 2024.

Scilex Holding Company - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
  • SaaS
Unique IDs
  • secCik: 0001820190
  • ticker: SCLX
  • ticker: SCLXW
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 18 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified